{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:00:40Z","timestamp":1793923240823,"version":"4.8.0"},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"44","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Copenhagen University Hospital\u2014Herlev and Gentofte, Gangstedfonden"},{"DOI":"10.13039\/501100025321","name":"Danish Cardiovascular Academy","doi-asserted-by":"crossref","award":["2022007-HF"],"award-info":[{"award-number":["2022007-HF"]}],"id":[{"id":"10.13039\/501100025321","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF20SA0067242"],"award-info":[{"award-number":["NNF20SA0067242"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007405","name":"Danish Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Dementia is a leading cause of death and disability that shares risk factors with atherosclerotic cardiovascular disease (ASCVD). High lipoprotein(a) is a causal risk factor for ASCVD while results for dementia are conflicting. With lipoprotein(a) lowering drugs in clinical trials, it was tested whether lipoprotein(a) levels are associated with the risk of Alzheimer\u2019s disease and\/or vascular-related dementia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Lipoprotein(a) measurements were available in 539 478 individuals from the Copenhagen General Population Study, the Copenhagen City Heart Study, and the UK Biobank. Individuals were followed for up to 30.2 years, during which 6404 developed Alzheimer\u2019s disease and 7866 vascular-related dementia. LPA kringle IV type 2 (KIV-2) number of repeats, which determines lipoprotein(a) isoform size and correlates inversely with lipoprotein(a) levels, were available in 117 029 individuals from the Copenhagen studies. Statistical analyses accounted for competing risk of death, important for studies of dementia occurring late in life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>On continuous scales, lipoprotein(a) levels were not associated with the risk of Alzheimer\u2019s disease or vascular-related dementia. When accounting for competing risk of death, absolute risks of vascular-related dementia increased with higher lipoprotein(a) levels in the UK Biobank (n = 452 989; events = 5132; P = .01), but not in the Copenhagen studies (n = 80 313; events = 2734; P = .42). In the Copenhagen studies, LPA KIV-2 number of repeats \u22645th vs &amp;gt; 50th percentiles associated with a subdistribution hazard ratio for Alzheimer\u2019s disease of 1.25 (95% confidence interval, 1.06\u20131.46).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Low lipoprotein(a) levels were not associated with the risk of Alzheimer\u2019s disease or vascular-related dementia. It cannot be excluded that very high lipoprotein(a) or small isoform size increases the risk of dementia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehaf465","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T07:38:55Z","timestamp":1750145935000},"page":"4779-4791","source":"Crossref","is-referenced-by-count":12,"title":["Lipoprotein(a) and risk of dementia: findings from three cohort studies"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9586-3914","authenticated-orcid":false,"given":"Peter E","family":"Thomas","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital\u2014Herlev and Gentofte , Borgmester Ib Juuls Vej 1, 2730 Herlev ,","place":["Denmark"]},{"name":"The Copenhagen General Population Study, Copenhagen University Hospital\u2014Herlev and Gentofte , Borgmester Ib Juuls Vej 1, 2730 Herlev ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Blegdamsvej 3B, 2200 Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0435-1110","authenticated-orcid":false,"given":"Signe","family":"Vedel-Krogh","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital\u2014Herlev and Gentofte , Borgmester Ib Juuls Vej 1, 2730 Herlev ,","place":["Denmark"]},{"name":"The Copenhagen General Population Study, Copenhagen University Hospital\u2014Herlev and Gentofte , Borgmester Ib Juuls Vej 1, 2730 Herlev ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Blegdamsvej 3B, 2200 Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sune F","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital\u2014Herlev and Gentofte , Borgmester Ib Juuls Vej 1, 2730 Herlev ,","place":["Denmark"]},{"name":"The Copenhagen General Population Study, Copenhagen University Hospital\u2014Herlev and Gentofte , Borgmester Ib Juuls Vej 1, 2730 Herlev ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1954-7220","authenticated-orcid":false,"given":"B\u00f8rge G","family":"Nordestgaard","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital\u2014Herlev and Gentofte , Borgmester Ib Juuls Vej 1, 2730 Herlev ,","place":["Denmark"]},{"name":"The Copenhagen General Population Study, Copenhagen University Hospital\u2014Herlev and Gentofte , Borgmester Ib Juuls Vej 1, 2730 Herlev ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Blegdamsvej 3B, 2200 Copenhagen ,","place":["Denmark"]},{"name":"The Copenhagen City Heart Study, Copenhagen University Hospital\u2014Bispebjerg and Frederiksberg , Nordre Fasanvej 57, 2000 Frederiksberg ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4084-5027","authenticated-orcid":false,"given":"Ruth","family":"Frikke-Schmidt","sequence":"additional","affiliation":[{"name":"The Copenhagen General Population Study, Copenhagen University Hospital\u2014Herlev and Gentofte , Borgmester Ib Juuls Vej 1, 2730 Herlev ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Blegdamsvej 3B, 2200 Copenhagen ,","place":["Denmark"]},{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital\u2014Rigshospitalet , Blegdamsvej 9, 2100 Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7627-6762","authenticated-orcid":false,"given":"Pia R","family":"Kamstrup","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Copenhagen University Hospital\u2014Herlev and Gentofte , Borgmester Ib Juuls Vej 1, 2730 Herlev ,","place":["Denmark"]},{"name":"The Copenhagen General Population Study, Copenhagen University Hospital\u2014Herlev and Gentofte , Borgmester Ib Juuls Vej 1, 2730 Herlev ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Blegdamsvej 3B, 2200 Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"2025112018523177200_ehaf465-B1","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the Lancet Standing Commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"key":"2025112018523177200_ehaf465-B2","volume-title":"World Alzheimer Report 2021: Journey Through the Diagnosis of Dementia","author":"Gauthier","year":"2021"},{"key":"2025112018523177200_ehaf465-B3","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S1474-4422(14)70136-X","article-title":"Potential for primary prevention of Alzheimer's disease: an analysis of population-based data","volume":"13","author":"Norton","year":"2014","journal-title":"Lancet Neurol"},{"key":"2025112018523177200_ehaf465-B4","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(24)01308-4","article-title":"Lipoprotein(a) and cardiovascular disease","volume":"404","author":"Nordestgaard","year":"2024","journal-title":"Lancet"},{"key":"2025112018523177200_ehaf465-B5","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1001\/jama.2025.2373","article-title":"Lipoprotein(a)","volume":"333","author":"Mora","year":"2025","journal-title":"JAMA"},{"key":"2025112018523177200_ehaf465-B6","doi-asserted-by":"publisher","first-page":"118614","DOI":"10.1016\/j.atherosclerosis.2024.118614","article-title":"Lipids, lipoproteins, and apolipoproteins: associations with cognition and dementia","volume":"398","author":"Rasmussen","year":"2024","journal-title":"Atherosclerosis"},{"key":"2025112018523177200_ehaf465-B7","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s10654-016-0184-0","article-title":"Is lipoprotein (a) protective of dementia?","volume":"31","author":"Kunutsor","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"2025112018523177200_ehaf465-B8","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1161\/circulationaha.120.045826","article-title":"Lipoprotein(a) in Alzheimer, atherosclerotic, cerebrovascular, thrombotic, and valvular disease: Mendelian randomization investigation","volume":"141","author":"Larsson","year":"2020","journal-title":"Circulation"},{"key":"2025112018523177200_ehaf465-B9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"Lipoprotein(a) reduction in persons with cardiovascular disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N Engl J Med"},{"key":"2025112018523177200_ehaf465-B10","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1056\/NEJMoa2211023","article-title":"Small interfering RNA to reduce Lipoprotein(a) in cardiovascular disease","volume":"387","author":"O'Donoghue","year":"2022","journal-title":"N Engl J Med"},{"key":"2025112018523177200_ehaf465-B11","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1001\/jama.2023.21835","article-title":"Lepodisiran, an extended-duration short interfering RNA targeting lipoprotein(a): a randomized dose-ascending clinical trial","volume":"330","author":"Nissen","year":"2023","journal-title":"JAMA"},{"key":"2025112018523177200_ehaf465-B12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1001\/jama.2024.24017","article-title":"Oral muvalaplin for lowering of lipoprotein(a): a randomized clinical trial","volume":"333","author":"Nicholls","year":"2025","journal-title":"JAMA"},{"key":"2025112018523177200_ehaf465-B13","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1001\/jama.2024.21957","article-title":"Zerlasiran\u2014a small-interfering RNA targeting lipoprotein(a): a phase 2 randomized clinical trial","volume":"332","author":"Nissen","year":"2024","journal-title":"JAMA"},{"key":"2025112018523177200_ehaf465-B14","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1194\/jlr.R067314","article-title":"Structure, function, and genetics of lipoprotein (a)","volume":"57","author":"Schmidt","year":"2016","journal-title":"J Lipid Res"},{"key":"2025112018523177200_ehaf465-B15","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"key":"2025112018523177200_ehaf465-B16","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"2025112018523177200_ehaf465-B17","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"2025112018523177200_ehaf465-B18","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"2025112018523177200_ehaf465-B19","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1194\/jlr.R071233","article-title":"Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology","volume":"57","author":"Nordestgaard","year":"2016","journal-title":"J Lipid Res"},{"key":"2025112018523177200_ehaf465-B20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/clinchem\/hvaa247","article-title":"Lipoprotein(a) and cardiovascular Disease","volume":"67","author":"Kamstrup","year":"2021","journal-title":"Clin Chem"},{"key":"2025112018523177200_ehaf465-B21","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/circulationaha.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"2025112018523177200_ehaf465-B22","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/s0140-6736(20)32233-9","article-title":"Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70\u2013100 years: a contemporary primary prevention cohort","volume":"396","author":"Mortensen","year":"2020","journal-title":"Lancet"},{"key":"2025112018523177200_ehaf465-B23","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"2025112018523177200_ehaf465-B24","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/eurheartj\/ehad055","article-title":"Lipoprotein(a) is linked to atherothrombosis and aortic valve stenosis independent of C-reactive protein","volume":"44","author":"Thomas","year":"2023","journal-title":"Eur Heart J"},{"key":"2025112018523177200_ehaf465-B25","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/j.jacc.2025.02.024","article-title":"Lipoprotein(a) cardiovascular risk explained by LDL cholesterol, non-HDL cholesterol, apoB, or hsCRP is minimal","volume":"85","author":"Thomas","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"2025112018523177200_ehaf465-B26","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1093\/clinchem\/46.12.1956","article-title":"Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a)","volume":"46","author":"Marcovina","year":"2000","journal-title":"Clin Chem"},{"key":"2025112018523177200_ehaf465-B27","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1093\/eurheartj\/ehy902","article-title":"High lipoprotein(a) and high risk of mortality","volume":"40","author":"Langsted","year":"2019","journal-title":"Eur Heart J"},{"key":"2025112018523177200_ehaf465-B28","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.jacc.2024.12.033","article-title":"Elevated remnant and LDL cholesterol and the risk of peripheral artery disease","volume":"85","author":"Wadstr\u00f6m","year":"2025","journal-title":"JACC"},{"key":"2025112018523177200_ehaf465-B29","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1210\/jc.2017-01049","article-title":"Effect of APOE \u025b genotype on lipoprotein(a) and the associated risk of myocardial infarction and aortic valve stenosis","volume":"102","author":"Kritharides","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2025112018523177200_ehaf465-B30","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1093\/eurheartj\/ehz402","article-title":"Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105949 individuals from a white general population cohort","volume":"40","author":"Rasmussen","year":"2019","journal-title":"Eur Heart J"},{"key":"2025112018523177200_ehaf465-B31","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.1093\/eurheartj\/ehaa695","article-title":"Impact of cardiovascular risk factors and genetics on 10-year absolute risk of dementia: risk charts for targeted prevention","volume":"41","author":"Juul Rasmussen","year":"2020","journal-title":"Eur Heart J"},{"key":"2025112018523177200_ehaf465-B32","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/alz.12165","article-title":"APOE and dementia\u2014resequencing and genotyping in 105,597 individuals","volume":"16","author":"Rasmussen","year":"2020","journal-title":"Alzheimers Dement"},{"key":"2025112018523177200_ehaf465-B33","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.cca.2011.05.036","article-title":"Lipoprotein(a)-cholesterol: a significant component of serum cholesterol","volume":"412","author":"Kinpara","year":"2011","journal-title":"Clin Chim Acta"},{"key":"2025112018523177200_ehaf465-B34","year":"2024"},{"key":"2025112018523177200_ehaf465-B35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2022.08.004","article-title":"Physical activity in leisure time and at work and risk of dementia: a prospective cohort study of 117,616 individuals","volume":"360","author":"Juul Rasmussen","year":"2022","journal-title":"Atherosclerosis"},{"key":"2025112018523177200_ehaf465-B36","doi-asserted-by":"publisher","first-page":"118470","DOI":"10.1016\/j.atherosclerosis.2024.118470","article-title":"Cardiovascular risk factors and risk of vascular-related dementia in high-risk and low-risk prospective cohort studies","volume":"395","author":"Rasmussen","year":"2024","journal-title":"Atherosclerosis"},{"key":"2025112018523177200_ehaf465-B37","doi-asserted-by":"publisher","first-page":"zwae364","DOI":"10.1093\/eurjpc\/zwae364","article-title":"Lipoprotein(a)-associated risk of atherosclerotic cardiovascular disease is independent of C-reactive protein","author":"Thomas","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2025112018523177200_ehaf465-B38","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-19425-7","volume-title":"Regression Modeling Strategies","author":"Harrell","year":"2015"},{"key":"2025112018523177200_ehaf465-B39","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/j.jacc.2023.10.009","article-title":"Lipoprotein(a) and risks of peripheral artery disease, abdominal aortic aneurysm, and major adverse limb events","volume":"82","author":"Thomas","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2025112018523177200_ehaf465-B40","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"2025112018523177200_ehaf465-B41","doi-asserted-by":"publisher","first-page":"k757","DOI":"10.1136\/bmj.k757","article-title":"Population attributable fraction","volume":"360","author":"Mansournia","year":"2018","journal-title":"BMJ"},{"key":"2025112018523177200_ehaf465-B42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jacc.2019.03.524","article-title":"Elevated lipoprotein(a) and risk of ischemic stroke","volume":"74","author":"Langsted","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2025112018523177200_ehaf465-B43","doi-asserted-by":"publisher","first-page":"18003","DOI":"10.1038\/nrdp.2018.3","article-title":"Vascular cognitive impairment","volume":"4","author":"van der Flier","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2025112018523177200_ehaf465-B44","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1016\/S0021-9258(18)83643-2","article-title":"Rhesus monkey apolipoprotein(a): sequence, evolution, and sites of synthesis","volume":"264","author":"Tomlinson","year":"1989","journal-title":"J Biol Chem"},{"key":"2025112018523177200_ehaf465-B45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/mol.0000000000000291","article-title":"Relation between plasma and brain lipids","volume":"27","author":"Wellington","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"2025112018523177200_ehaf465-B46","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-022-00566-4","article-title":"APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer\u2019s disease pathology and brain diseases","volume":"17","author":"Fern\u00e1ndez-Calle","year":"2022","journal-title":"Mol Neurodegener"},{"key":"2025112018523177200_ehaf465-B47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11883-024-01192-9","article-title":"Novel therapies for lipoprotein(a): update in cardiovascular risk estimation and treatment","volume":"26","author":"Wulff","year":"2024","journal-title":"Curr Atheroscler Rep"},{"key":"2025112018523177200_ehaf465-B48","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/S0022-2275(20)31975-1","article-title":"Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype","volume":"41","author":"Frikke-Schmidt","year":"2000","journal-title":"J Lipid Res"},{"key":"2025112018523177200_ehaf465-B49","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1001\/jama.2010.574","article-title":"Genome-wide analysis of genetic loci associated with Alzheimer disease","volume":"303","author":"Seshadri","year":"2010","journal-title":"JAMA"},{"key":"2025112018523177200_ehaf465-B50","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat Genet"},{"key":"2025112018523177200_ehaf465-B51","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","article-title":"Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk","volume":"51","author":"Jansen","year":"2019","journal-title":"Nat Genet"},{"key":"2025112018523177200_ehaf465-B52","doi-asserted-by":"publisher","first-page":"101695","DOI":"10.1016\/j.eclinm.2022.101695","article-title":"Serum lipid traits and the risk of dementia: a cohort study of 254,575 women and 214,891 men in the UK Biobank","volume":"54","author":"Gong","year":"2022","journal-title":"EClinicalMedicine"},{"key":"2025112018523177200_ehaf465-B53","doi-asserted-by":"publisher","first-page":"e2313734","DOI":"10.1001\/jamanetworkopen.2023.13734","article-title":"Genetic associations between modifiable risk factors and Alzheimer disease","volume":"6","author":"Luo","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2025112018523177200_ehaf465-B54","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1440-1819.1987.tb00433.x","article-title":"Lp(a) lipoprotein in cerebrovascular disease and dementia","volume":"41","author":"Urakami","year":"1987","journal-title":"Jpn J Psychiatry Neurol"},{"key":"2025112018523177200_ehaf465-B55","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3143\/geriatrics.29.559","article-title":"Serum lipids, lipoproteins and apolipoproteins in patients with senile dementia [in Japanese]","volume":"29","author":"Kuriyama","year":"1992","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"2025112018523177200_ehaf465-B56","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000017226","article-title":"Lipoprotein(a) phenotypes in patients with vascular dementia","volume":"11","author":"Urakami","year":"2000","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2025112018523177200_ehaf465-B57","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000079200","article-title":"Relation of apolipoprotein(a) size to Alzheimer's disease and vascular dementia","volume":"18","author":"Emanuele","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2025112018523177200_ehaf465-B58","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.metabol.2003.11.020","article-title":"Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia","volume":"53","author":"Watanabe","year":"2004","journal-title":"Metabolism"},{"key":"2025112018523177200_ehaf465-B59","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1479-8301.2004.00063.x","article-title":"Dual inverse effects of lipoprotein(a) on the dementia process in Japanese late-onset Alzheimer's disease","volume":"4","author":"Iwamoto","year":"2004","journal-title":"Psychogeriatrics"},{"key":"2025112018523177200_ehaf465-B60","doi-asserted-by":"publisher","first-page":"179","DOI":"10.5551\/jat.E608","article-title":"Increased plasma urotensin-II and carotid atherosclerosis are associated with vascular dementia","volume":"16","author":"Ban","year":"2009","journal-title":"J Atheroscler Thromb"},{"key":"2025112018523177200_ehaf465-B61","first-page":"57","article-title":"Serum homocysteine, dehydroepiandrosterone sulphate and lipoprotein (a) in Alzheimer's disease and vascular dementia","volume":"4","author":"Ray","year":"2013","journal-title":"Aging Dis"},{"key":"2025112018523177200_ehaf465-B62","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1136\/jnnp.72.6.732","article-title":"Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease","volume":"72","author":"Solfrizzi","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025112018523177200_ehaf465-B63","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1600-0404.1999.tb00724.x","article-title":"Increased apolipoprotein B serum concentration in Alzheimer's disease","volume":"100","author":"Caramelli","year":"1999","journal-title":"Acta Neurol Scand"},{"key":"2025112018523177200_ehaf465-B64","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2318-1-5","article-title":"Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease","volume":"1","author":"Zuliani","year":"2001","journal-title":"BMC Geriatr"},{"key":"2025112018523177200_ehaf465-B65","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.neulet.2003.12.043","article-title":"Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease","volume":"357","author":"Emanuele","year":"2004","journal-title":"Neurosci Lett"},{"key":"2025112018523177200_ehaf465-B66","doi-asserted-by":"publisher","first-page":"533","DOI":"10.7326\/0003-4819-132-7-200004040-00004","article-title":"Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease","volume":"132","author":"Mooser","year":"2000","journal-title":"Ann Intern Med"},{"key":"2025112018523177200_ehaf465-B67","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1161\/strokeaha.119.026872","article-title":"Causal effect of lp(a) [lipoprotein(a)] level on ischemic stroke and Alzheimer disease: a Mendelian randomization study","volume":"50","author":"Pan","year":"2019","journal-title":"Stroke"},{"key":"2025112018523177200_ehaf465-B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"2025112018523177200_ehaf465-B69","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000107084","article-title":"Validity of dementia diagnoses in the Danish hospital registers","volume":"24","author":"Phung","year":"2007","journal-title":"Dement Geriatr Cogn Disord"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/44\/4779\/64078529\/ehaf465.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/44\/4779\/64078529\/ehaf465.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T23:52:41Z","timestamp":1763682761000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/46\/44\/4779\/8237435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":69,"journal-issue":{"issue":"44","published-online":{"date-parts":[[2025,8,18]]},"published-print":{"date-parts":[[2025,11,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaf465","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11,21]]},"published":{"date-parts":[[2025,8,18]]}}}